Universitätsklinikum Würzburg

CAR T-Cells in Multiple Myeloma: State of the Art and Future Directions (2020) Gerardo Rodriguez-Lobato L, Ganzetti M, Fernandez De Larrea C, Hudecek M, Einsele H, Danhof S Journal article, Review article A minority of T cells recognizing tumor-associated antigens presented in self-HLA can provoke antitumor reactivity (2020) Roex MCJ, Hageman L, Veld SAJ, Van Egmond E, Hoogstraten C, Stemberger C, Germeroth L, et al. Journal article Glycine ReceptorAutoantibodies Impair Receptor Function and Induce Motor Dysfunction (2020) Rauschenberger V, Von Wardenburg N, Schaefer N, Ogino K, Hirata H, Lillesaar C, Kluck C, et al. Journal article Meta-analysis of leukocyte diversity in atherosclerotic mouse aortas (2020) Zernecke A, Winkels H, Cochain C, Williams JW, Wolf D, Soehnlein O, Robbins CS, et al. Journal article, Review article Chemically Programmable and Switchable CAR-T Therapy (2020) Qi J, Tsuji K, Hymel D, Burke TR, Hudecek M, Rader C, Peng H Journal article Intravital imaging of megakaryocytes (2020) Stegner D, Heinze KG Journal article, Review article Multiple myeloma—dynamic developments regarding disease understanding and therapy Multiples Myelom – dynamische Entwicklungen in Krankheitsverständnis und Therapie (2020) Steinbrunn T, Knop S, Einsele H Journal article Host immune genetic variations influence the risk of developing acute myeloid leukaemia: results from the NuCLEAR consortium (2020) Sanchez-Maldonado JM, Campa D, Springer J, Badiola J, Niazi Y, Moniz-Diez A, Hernandez-Mohedo F, et al. Journal article Bispecific antibodies: A new era of treatment for multiple myeloma (2020) Zhou X, Einsele H, Danhof S Journal article, Review article RADIANCE – Radiochemotherapy with or without Durvalumab in the treatment of anal squamous cell carcinoma: A randomized multicenter phase II trial (2020) Martin D, Balermpas P, Gollrad J, Weiss C, Valentini C, Stuschke M, Schaefer H, et al. Journal article